- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01818089
Monitoring of Lung Sounds of Patients With Pneumonia
September 22, 2015 updated by: RWTH Aachen University
The aim of this study is to investigate if any correlation between lung sounds of pneumonia patients and the clinical development or therapy of the pneumonia exists.
Study Overview
Study Type
Observational
Enrollment (Actual)
17
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Rhine Westfalia
-
Aachen, North Rhine Westfalia, Germany, 52074
- Univeristy Hospital Aachen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients with ambulant aquired pneumonia
Description
Inclusion Criteria:
- ambulant aquired pneumonia with typically radiological signs
- hospitalisation at medical clinic I, university hospital Aachen
- age at least > 18 years
- CRB-65 score > 1
- CRP> 60mg/l
- fever
- lung sounds audible by stethoscope
- legal capacity and being able to understand and to follow the instructions of the study staff
- being able to consent and being able to understand the importance and the consequence of the study
- not being accomondated in an institution
Exclusion Criteria:
- pneumonia acquired in a hospital
- artificial respiration or other means for supporting respiration
- allergic reaction because of skin contact with polymers
- pregnancy or breast feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Lung Sound Analyzer
Patient with pneumonia admitted to hospital will receive additional auscultation with lung sound analyzing stethoscope
|
Patients will be aucultated with lung sound analyzer.
The auscultation will be done three times daily during the duration of the complete hospital stay.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sound of lungs
Time Frame: 5 days
|
3 times a day for longest 5 days
|
5 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christian Cornelissen, MD, RWTH Aachen University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
February 15, 2013
First Submitted That Met QC Criteria
March 21, 2013
First Posted (Estimate)
March 26, 2013
Study Record Updates
Last Update Posted (Estimate)
September 23, 2015
Last Update Submitted That Met QC Criteria
September 22, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-116
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Department of Health and Human ServicesNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Methodist Health SystemCompletedHospital-acquired Pneumonia | Ventilator-associated PneumoniaUnited States
Clinical Trials on Lung sound analyzer
-
Maximilian NussbaumerCambridge University Hospitals NHS Foundation TrustTerminatedLung Neoplasms | Pulmonary Disease, Chronic Obstructive | Asthma | Lung Diseases, Interstitial | BronchomalaciaUnited Kingdom
-
Smolle-Juettner Freyja, Prof MDGraz University of TechnologyCompleted
-
University of EdinburghProjahnmo Research FoundationCompleted
-
Loma Linda UniversityWithdrawn
-
University of California, San FranciscoJohns Hopkins University; National Institute of Allergy and Infectious Diseases... and other collaboratorsRecruitingTuberculosis | Diagnostics | Global HealthMozambique, South Africa, Uganda
-
Medical University of LodzCompletedAsthma | Allergic Rhinitis | Atopic DermatitisPoland
-
Sight DiagnosticsCompleted
-
American University of Beirut Medical CenterCompleted
-
University of Maryland, BaltimoreHemoSonics LLCCompletedHemorrhage | Coagulation DelayUnited States
-
University of Mississippi Medical CenterVicor Technologies, Inc.CompletedAutonomic DysfunctionUnited States